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ABSTRACTS0329: PATIENT ACCESS TO IMMEDIATE BREAST RECONSTRUCTION
FOLLOWING CANCER SURGERY. LEARNING FROM THE NATIONAL MAS-
TECTOMY AND BREAST RECONSTRUCTION AUDIT (NMBRA)
Senthurun Mylvaganam, Niraj Vethirajan, Khalid Boussouara,
George Metaxas, Hemant Ingle. Good Hope Hospital, Heart of England NHS
Trust, Sutton Coldﬁeld, Birmingham, UK.
Introduction: NICE guidance requires breast reconstruction discussionwith
all patients requiring mastectomy. The national mastectomy and recon-
struction audit showed signiﬁcant variation in accessibility and practice
in NHS Trusts offering breast reconstruction. Our trust service has evolved
since the audit combining breast and dedicated plastic surgeons on site.
Aims: Assess current local accessibility and practice for offering immediate
breast reconstruction following mastectomy.
Methods: Retrospective analysis of patients undergoing mastectomy for
cancer at Heart of England NHS trust (HEFT) between September 2011 to
July 2012. Data collected on tumour biology, whether reconstruction op-
tions offered and if not performed why.
Results: N¼76. Mean Nottingham Prognostic Index(NPI)¼4.03. Mean
age¼61(31-90)
Immediate reconstruction offered ¼46%. Immediate reconstruction per-
formed ¼25%. Reconstruction techniques; immediate with expander(2),
immediate delayed with expander(5), Transverse Rectus Abdominis
Myocutaneous(TRAM) free ﬂap(7), Lattissimus Dorsi(LD) pedicled ﬂap(2),
LD with implant(2), Deep Inferior Epigastric Perforator(DIEP) free ﬂap(1).
Reasons reconstruction not performed; patient choice(8), patient choosing
delayed(6).
Conclusion: Our trust breast cancer service is a partnership between
breast and plastic surgeons with joint MDT and clinic services. The trust
rate of discussion of immediate reconstruction is greater than
the published NMBRA local cancer network rate(36%). An integrated
oncoplastic service is a key measure towards fulﬁlling NICE guidance.
0331: THE IMPORTANCE OF NEEDLE CORE BIOPSY IN THE DIAGNOSIS
OF PHYLLOIDES TUMOURS
Senthurun Mylvaganam1, Lucinda Frank 2, Clare Toro 1, Sarah Vestey 2,
Steven Thrush 1. 1Worcester Royal Hospital, Worcestershire Acute NHS Trust,
Worcester, Worcestershire, UK; 2Gloucestershire Hospitals NHS Trust,
Gloucester, Gloucestershire, UK.
Introduction: Phylloides tumours are rare ﬁbroepithelial breast tumours
and are usually clinically and radiological indistinguishable from ﬁbroa-
denomas. This makes core biopsy the main method of diagnosis. Only
small studies have looked at the diagnostic histological accuracy of needle
core biopsy(NCB) and none have addressedwhether there is any variability
of NCB accuracy between institutions.
Aims: To assess the diagnostic accuracy of NCB compared to the gold
standard excision biopsy report in 2 separate hospitals trusts.
Methods: Multicentre retrospective analysis of all cases of phylloides tu-
mours on core and/or excision biopsy from March 2006 to July 2012 at
Worcestershire Acute NHS Trust (WAHNST) and Gloucestershire hospitals
NHS Trust (GHNHST).
Results: N¼94. Mean age¼48. Mean clinical size¼31.7mm, mean radio-
logical size¼35.4mm. WAHNST n¼42. NCB Sensitivity¼87% and Positive
Predictive Value(PPV)¼90%. GHNHST n¼52 NCB Sensitivity¼74% and
PPV¼100%.
Conclusion: The high sensitivity of NCB shown demonstrates its impor-
tance in the diagnosis of Phylloides tumours (comparative study in liter-
ature 63%). There does appear to be variation between pathologists in
interpretation of NCB, which may be caused by the interpretation of the
criteria for diagnosing Phylloides. NCB is not 100% sensitive at diagnosing
these tumours so there must be local protocols to ensure tumours are not
missed.
0434: BREAST CANCER SURGERY IS SAFE IN THE ELDERLY PATIENT
Ramesh Yap Kannan, Nadi Khaldoun, Khawaja Saira, Sumrien Haytham,
Holt Simon, Sharaiha Yousef. Prince Philip Hospital, Llanelli,
Carmarthenshire, UK.
Aims: To assess the safety of surgical resection of breast cancer in patients
over 70 years
Methodology: A retrospective study of 188 consecutive patients diag-
nosed with breast cancer at the age of 70 or older (2004 to 2008). Noteswere examined for demographics, treatment, complications and ﬁnal
outcome. Patients received surgery with an intent to cure (SC) or conser-
vative treatment (C).
Results: 68 patients received C and 120 patients underwent SC. SC was
performed in 63.8%(120 of 188), of whom 93.3% had a general anaesthetic.
Mastectomy (M) was performed in 51.6%, M following a wide local excision
(WLE) in 4.2% and WLE in 44.2%. Axillary surgery (n¼93) was either an
axillary sampling (AS) in 5%, AS and clearance (AC) in 1%, primaryAC in87.1%,
sentinel node biopsy (SNB) in 3.2% and SNB followed by AC in 3.2% (3 of 93).
30 day mortality was 0.008% (1 of 120) following a myocardial infarction. 10
patients had minor complications. Median follow up (SC) was 24 months
versus 20 months (C). Overall survival was 89%(SC) versus 50% (C).
Conclusion: Elderly patients with breast cancer, can be treated surgically
with an intent to cure, safely and this has an impact on survival.
0470: A RETROSPECTIVE ANALYSIS OF PHYLLODES TUMOURS AND B3
LESIONS ON CORE BIOPSY
Lucinda Frank, Sarah Vestey, Richard Bryan. Gloucester Royal Hospital,
Gloucester, UK.
Aim: To determine the accuracy of core biopsies in diagnosing Phyllodes
tumours.
Method: A retrospective analysis of all cases of Phyllodes tumours on
excision biopsy was undertaken from March 2006 e July 2012. This was
then cross-referenced with all B3 lesions on core biopsy for the same time
period.
Results: 59 cases of Phyllodes tumour were identiﬁed in Gloucester and
Cheltenham NHS trust. These cases were classiﬁed as B2, B3 and B4 on core
biopsy. 15% Phyllodes tumours were classiﬁed as ﬁbroadenomas on core
biopsy. 69% cases were classiﬁed as B3. 48/392 B3 core biopsies in the same
time period raised the possibility of a Phyllodes tumour, 33 of these were
conﬁrmed as Phyllodes tumours on excision.
Conclusion: A high index of suspicion of Phyllodes tumours is important
when analysing core biopsies as this will dictate whether cavity shaves are
taken at the time of excision. A signiﬁcant number of patients had Phyl-
lodes tumours diagnosed on excision biopsy following a B2 core biopsy,
this highlights a need to educate patients about the risk of Phyllodes tu-
mours if their breast lump increases in size or changes as Phyllodes tu-
mours represent an ongoing diagnostic challenge.
0495: PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN
AN IRISH POPULATION OF PATIENTS WITH BREAST CANCER
Eamon Francis, Aoife Lowery, Ruth Prichard, James Geraghty, Denis Evoy,
Enda Mc Dermott. St Vincents University Hospital, Dublin 4, Ireland.
Aims: This study aimed to determine the rate of complete pathological
response (pCR) following neoadjuvant chemotherapy and identify clinico-
pathologic factors, with speciﬁc reference to Her2 status, associated with a
pCR. It assessed the validity and applicability of the MD Anderson nomo-
gram to predict response to neoadjuvant chemotherapy.
Methods: Ninety patients who received neoadjuvant chemotherapy
within a ﬁve year period were identiﬁed. Patient demographics, patho-
logical tumour characteristics were recorded. The probability of a pCR was
calculated using the Neo!adjuvant nomogram to etermine its accuracy in
an Irish population.
Results: Eighty-seven patients were included in the ﬁnal analysis. Overall,
13.79% (n¼12) of patients had a pCR. All tumours exhibiting a pCR were
invasive ductal carcinomas. The absence of LVI was statistically signiﬁcant
in predicting pCR (p¼ <0.05). Oestrogen receptor (ER) positivity and HER2
positivity were also signiﬁcantly associated with a pCR (p¼ <0.05). The
application of the MD Anderson Neo!adjuvant nomogram to our Irish
cohort of patients with breast cancer was validated with an area under the
curve (AUC) of 0.722.
Conclusion: pCR is associated with invasive ductal carcinoma, the absence
of lymphovascular invasion, oestrogen negativity and Her2 receptor pos-
itivity. The Neo!adjuvant nomogram for women undergoing neoadjuvant
chemotherapy was validated.
0499: BLUE DYE IN SENTINEL LYMPH NODE BIOPSY FOR BREAST CAN-
CER. ARE WE FOLLOWING THE GUIDELINES?
Sudin Daniel, Abraham Mathew, Ali Nejim. Airedale General Hospital,
Keighley, West Yorkshire, UK.
